European automotive and pharma stocks brace for Trump’s policies

Donald Trump’s return to the presidency brings potential trade changes that may impact European automotive and pharmaceutical companies. Proposed tariffs could affect exports from the EU to the US, with automotive manufacturers facing immediate revenue challenges due to the high proportion of sales linked to the American market. While some automakers maintain production capacity in the US, others may consider costly long-term shifts in production. The pharmaceutical sector could see similar pressures, though critical demand and existing US investments offer some insulation. These developments...